Mirum Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $77,875 | $69,222 | $69,554 | $47,725 |
Gross Profit | 57,494 | 51,392 | 46,950 | 37,497 |
EBITDA | -18,378 | -15,414 | -24,676 | -25,148 |
EBIT | -24,232 | -21,078 | -30,075 | -27,810 |
Net Income | -24,638 | -25,279 | -33,149 | -23,588 |
Net Change In Cash | 77,875 | 69,222 | 69,554 | 47,725 |
Free Cash Flow | -14,582 | 15,199 | -21,617 | -18,221 |
Cash | 233,245 | 302,843 | 286,326 | 303,059 |
Basic Shares | 47,235 | 46,927 | 46,723 | 41,098 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $186,374 | $77,062 | $19,138 | $11,000 |
Gross Profit | 139,006 | 64,688 | 17,235 | -623 |
EBITDA | -98,325 | -126,998 | -64,654 | -102,929 |
EBIT | -109,154 | -130,679 | -65,629 | -103,552 |
Net Income | -163,415 | -135,665 | -83,988 | -103,270 |
Net Change In Cash | 186,374 | 77,062 | 19,138 | 11,000 |
Cost of Revenue | -3,349 | -10,745 | 130,087 | |
Free Cash Flow | -91,053 | -120,414 | -151,782 | -89,300 |
Cash | 286,326 | 28,003 | 31,340 | 142,086 |
Basic Shares | 40,885 | 33,839 | 30,321 | 25,251 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.52 |
2024-03-31 | -$0.54 |
2023-12-31 | -$0.66 |
2023-09-30 | -$0.57 |
